Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hikma Pharmaceuticals Plc (HKMPF)

Hikma Pharmaceuticals Plc (HKMPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hikma Pharmaceuticals Plc 1 New Burlington Place London X0 W1S 2HR GBR

www.hikma.com Employees: 9,500 P: 44-20-7399-2760

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Hikma Pharmaceuticals PLC develops, manufactures and markets pharmaceutical products. Its brand portfolio includes branded, injectables and generic. Branded segment offers dosage forms and strengths in the anti-infective, cardiovascular, diabetes, central nervous system, oncology and respiratory. Injectables segment offers dosage for CNS, controlled substances, anti-infective, cardiovascular and oncology in form of liquid, semi-liquid and powdered form. Generics segment offers dosage for therapeutic including analgesic, anti-infective, anti-inflammatory, cardiovascular, CNS, respiratory and hormonal. Hikma Pharmaceuticals PLC is based in London, the United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 3,993,948
Enterprise Value, $K 5,054,948
Shares Outstanding, K 221,886
Float, K 221,886
% Float 100.00%
Short Interest, K 133
Short Float 0.06%
Days to Cover 38.55
Short Volume Ratio 0.92
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 3,127 M
Annual Net Income, $ 359,000 K
EBIT, $ 0 K
EBITDA, $ 853,000 K

Growth:

1-Year Return -33.76%
3-Year Return -48.48%
5-Year Return 0.00%
5-Year Revenue Growth 41.69%
5-Year Earnings Growth 47.33%
5-Year Dividend Growth 97.50%

Per-Share Information:

Next Earnings Date 05/28/26
Earnings Per Share ttm 0.00
Annual Dividend & Yield (Paid) 0.84 (4.67%)
Annual Dividend & Yield (Fwd) 0.72 (4.00%)
Most Recent Dividend 0.360 on 08/15/25
Next Ex-Dividends Date 03/20/26
Dividend Payable Date 04/30/26
Dividend Payout Ratio 0.00%

HKMPF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 11.48%
Debt/Equity 0.59
Price/Sales 1.19
Price/Cash Flow 8.07
Price/Book 1.57
Book Value/Share 11.50
Interest Coverage 3.72
60-Month Beta 0.59

HKMPF Dividends

Date Value
08/15/25 $0.3600
03/21/25 $0.4800
08/16/24 $0.3200
03/21/24 $0.4700
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar